Response to ruxolitinib in patients with intermediate-1-, intermediate-2-, and high-risk myelofibrosis: results of the UK ROBUST Trial (Q33421596)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Response to ruxolitinib in patients with intermediate-1-, intermediate-2-, and high-risk myelofibrosis: results of the UK ROBUST Trial
scientific article

    Statements

    Response to ruxolitinib in patients with intermediate-1-, intermediate-2-, and high-risk myelofibrosis: results of the UK ROBUST Trial (English)
    0 references
    Dragana Milojkovic
    Steven Knapper
    Joseph Chacko
    Mira Farquharson
    Richard E Clark
    Chris Andrews
    Meryem Ktiouet Dawson
    Claire Harrison

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit